20/20 Biolabs, Inc. (AIDX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 8-K | Shareholder Vote Results | SEC |
| 2026-08-17 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-08-05 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-22 | 8-K | Material Agreement, Listing Notice, Financial Statements & Exhibits | SEC |
| 2026-07-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-26 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-05-20 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-28 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-04-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.